Gene Expression Changes in the Ovary Mediate Non-Anovulatory Mechanisms of Contraception with Levonorgestrel

Arch Med Res. 2023 Nov;54(7):102892. doi: 10.1016/j.arcmed.2023.102892. Epub 2023 Oct 5.

Abstract

Background: Emergency contraception with levonorgestrel (LNG) is a viable option to prevent unintended pregnancies. Although the efficacy of LNG as an anovulatory agent decreases as treatment approaches ovulation, it still provides some contraceptive benefits.

Aim: To better understand the contraceptive mechanisms of LNG in ovulatory subjects.

Methods: We conducted a study on Wistar rats that received a single dose of LNG (0.01 or 0.05 mg/kg) on the morning of proestrus before ovulation and evaluated its effects on ovarian gene expression, ovulation, and implantation.

Results: Our findings showed changes in the expression of genes involved in follicular development and oocyte quality. Pregnancy rates - as an indicator of ovulation - and embryo implantation were significantly lower than those in the control group.

Conclusions: This study suggests that LNG alters regulatory factors in the ovary that are essential for the development of competent fertilizable oocytes, highlighting the non-anovulatory mechanisms by which levonorgestrel may regulate fertility and suggesting that it could be a novel observation that contributes to the understanding of emergency contraception in humans.

Keywords: Emergency contraception; Estrus cycle; Levonorgestrel; Ovulation; Pregnancy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Contraception
  • Contraceptive Agents / pharmacology
  • Female
  • Gene Expression
  • Humans
  • Levonorgestrel* / pharmacology
  • Ovary* / physiology
  • Pregnancy
  • Rats
  • Rats, Wistar

Substances

  • Levonorgestrel
  • Contraceptive Agents